Market Performance - The US stock market showed mixed performance, with the Dow Jones Industrial Average rising by 0.55% to close at 49,266.11, while the S&P 500 saw a slight increase of 0.01% to 6,921.46, and the Nasdaq Composite fell by 0.44% to 23,480.02 [1] - Major tech stocks experienced a pullback, with Broadcom down 3.21%, Nvidia down 2.19%, and Apple declining for the seventh consecutive trading day, down 0.5% [1] - Conversely, some large tech stocks rose, including Amazon up 1.96%, Alphabet up 1.1%, and Tesla up 1.02% [2] Chinese Market Insights - The Nasdaq China Golden Dragon Index increased by 1.09%, with Alibaba rising by 5.29%, JD.com by 2.20%, and Pinduoduo by 0.52%, while Baidu fell by 3.78% [3] Commodity Prices - WTI crude oil for February delivery rose by $1.77 to $57.76 per barrel, marking a 3.16% increase [4] - Gold prices remained stable, with spot gold at $4,452.64 per ounce and futures gold slightly down to $4,460.70 [5] Regulatory Developments - The Chinese market regulator held discussions with major photovoltaic companies regarding monopoly risks and required them to submit written rectification measures by January 20 [6] - The Guangzhou government issued a plan to accelerate the development of advanced manufacturing, focusing on low-altitude economy and commercial aerospace, aiming to establish a series of launch vehicle industry bases [7] Corporate Actions - China Petroleum and Chemical Corporation is undergoing a restructuring with China Aviation Oil [7] - Notable corporate announcements include Vanke A's executive retirement, and several companies reporting significant expected losses or restructuring plans [7]

Group 1 - The core point of the article is that China Seed Group has completed the acquisition of shares in Qianyuan High-Tech, making it the largest shareholder with a 40.51% stake [2][4] - The acquisition involved approximately 2.245 billion yuan, with a purchase price of 11.85 yuan per share for 189,466,350 shares, representing 20% of the total share capital [3] - Following the acquisition, China Seed Group has committed to not transferring its shares for 18 months, except for transfers between entities under the same actual controller [4] Group 2 - Qianyuan High-Tech is a high-tech seed industry enterprise engaged in the research, breeding, promotion, and service of major crops such as rice, corn, and wheat [5] - The acquisition aims to resolve long-standing issues of competition between China Seed Group and Qianyuan High-Tech, as both companies operate in similar sectors [5] - In the first three quarters of 2025, Qianyuan High-Tech reported a revenue of 1.934 billion yuan, a year-on-year decrease of 5.90%, and a net loss of 180 million yuan [6]

Major Announcements - Tongcheng New Materials is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy and financing channels [2] - Huaxia Happiness's controlling shareholder and actual controller are involved in arbitration with a claim amount of approximately 6.4 billion yuan [5] - Industrial Fulian announced a cash dividend distribution of 6.55 billion yuan for the first half of 2025, with a record date of January 15, 2026 [6] Stock Trading Risks - Fenglong Co. reported significant stock price volatility, with a cumulative increase of over 20% in two consecutive trading days, indicating high speculation risk [3] - Guojiji Heavy Industry stated that its revenue from controllable nuclear fusion products is currently very low, despite being classified as a related stock [4] - China Nuclear Construction highlighted that its controllable nuclear fusion business has not generated any revenue yet [11][15] Financial Performance - Puni Testing expects a loss of 200 million to 250 million yuan for the fiscal year 2025, following a 100% increase in stock price over ten trading days [18] - Meike Home anticipates a negative net profit for 2025, indicating financial challenges [19] - Jinli Permanent Magnet forecasts a net profit increase of 127% to 161% for 2025, driven by strong sales in various sectors [20] New Business Developments - Aibisen received a drug registration certificate for its exclusive injectable botulinum toxin product, marking a significant milestone in its strategic layout [14] - Changhong Technology's subsidiary secured over half of the procurement share for semiconductor materials from a major domestic wafer factory, enhancing its market position [30] Share Buybacks and Reductions - Xingchen Technology plans to repurchase shares worth 60 million to 120 million yuan for employee stock ownership plans [22] - *ST Jianyi's shareholder plans to reduce holdings by up to 1.23% of total shares [23] - Lai Yifen's controlling shareholder intends to reduce holdings by up to 3% of the company's shares [25]

格隆汇1月8日丨荃银高科(300087.SZ)公布，截至2026年1月5日，本次要约收购期限届满。根据中国证 券登记结算有限责任公司深圳分公司提供的数据统计，在2025年12月4日至2026年1月5日要约收购期限 内，最终有3,763个账户，共计297,787,643股股份接受收购人发出的要约，根据要约收购报告书，若预 受要约股份的数量超过189,466,350股，收购人按照同等比例收购预受要约的股份，计算公式如下：收购 人从每个预受要约股东处购买的股份数量＝该股东预受要约的股份数×（189,466,350股÷要约期间所有 股东预受要约的股份总数）。收购人从每名预受要约的股东处购买的股份如涉及不足一股的余股，则将 按照中登公司权益分派中零碎股的处理办法进行处理。本次要约收购完成后，收购人中种集团持有公司 383,760,376股股份，占公司总股本的40.51%。本次要约收购不以终止上市公司上市地位为目的，本次 要约收购后上市公司的股权分布将仍然符合深圳证券交易所规定的上市条件。现要约收购结果已确认， 经申请，公司股票将于2026年1月9日（星期五）上午开市起复牌。 ...

Suspension - ChuanYin High-Tech: China Seed Group intends to acquire 298 million shares, stock to resume trading [1] - HuiBoPu: Water Industry Group plans to transfer 25%-30% of company shares, stock suspended [1] - TianSheng New Materials: Major shareholder Wu Haizhou is planning significant matters that may lead to a change in control, stock suspended [2] Private Placement and Mergers - RiJiu Optoelectronics: Plans to raise no more than 800 million yuan for a project to produce 6 million square meters of functional films and to supplement working capital [3] - QuanXin Co., Ltd.: Plans to issue convertible bonds to raise no more than 1.2 billion yuan for the production of integrated products for commercial aviation transmission and communication [3] - BeiFang ChangLong: Plans to acquire 51% of Shunyi Technology, expected to constitute a major asset restructuring [3] Share Buybacks - XingChen Technology: Plans to repurchase shares for 60 million to 120 million yuan, with a maximum repurchase price of 88.90 yuan per share [4] - XinKaiYuan: Plans to repurchase shares for 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [4] External Investments and Daily Operations - RunJian Co., Ltd.: Signed a strategic cooperation framework agreement with JD Technology to expand cooperation in AI applications and intelligent computing cloud [4] - YueDianLi A: The expansion project of Huizhou Power Plant Units 5 and 6 (2×1000MW) has a total investment of 8.05 billion yuan, with Unit 5 now in operation [5] - ZhongWu Drone: Signed a contract for drone systems worth over 100 million yuan, expected to positively impact annual operating performance [6] - TianNeng Co., Ltd.: Plans to use no more than 12 billion yuan of self-owned funds for entrusted wealth management [7] - ChangHong Technology: Its subsidiary has secured over half of the procurement share from a major domestic wafer factory for semiconductor consumables by 2026 [7] - AiMeiKe: Exclusive distributor of injectable type A botulinum toxin products has obtained drug registration certificate [7] - KangTai Biology: Clinical trial application for acellular pertussis-diphtheria-tetanus combined vaccine has been accepted [8] - PaiRui Co., Ltd.: Signed a framework agreement for bulk procurement of IGBT chips, with total supply amounting to approximately 1.3 to 1.4 billion yuan for 2028, 2029, and 2030 [8] Performance Changes - JinLi YongCi: Expected net profit of 660 million to 760 million yuan in 2025, a year-on-year increase of 127%-161% due to small batch deliveries of robotic motor rotors and magnetic materials [9] - YingQu Technology: Expected net profit of 540 million to 660 million yuan in 2025, a year-on-year increase of 114.69%-162.40%, with significant fair value changes from equity investments expected to add 381 million yuan to net profit [9] - AiBiSen: Expected net profit of 240 million to 290 million yuan in 2025, a year-on-year increase of 105.32%-148.09% [9] - WenShi Co., Ltd.: Expected net profit in 2025 to decrease by 40.73%-46.12% year-on-year due to declining profits in pig and chicken farming [9]

荃银高科1月8日公告，在2025年12月4日至2026年1月5日要约收购期限内，最终有3763个账户接受中种 集团发出的要约，共计2.98亿股股份。根据要约收购报告书，若预受要约股份的数量超过1.89亿股，中 种集团将按照同等比例收购预受要约的股份。本次要约收购完成后，中种集团持有公司3.84亿股股份， 占公司总股本的40.51%。公司股票将于1月9日复牌。 ...

每经AI快讯，荃银高科1月8日晚间发布公告称，公司于2025年12月3日披露了中种集团送达的《安徽荃 银高科种业股份有限公司要约收购报告书》，中种集团向除中种集团以外的公司全体股东发出的部分要 约，要约价格为11.85元/股，要约收购股份数量约1.89亿股，占上市公司总股本的20%。本次要约收购 期限为2025年12月4日至2026年1月5日。截至本公告日， 截至2026年1月5日，本次要约收购期限届满。根据中国证券登记结算有限责任公司深圳分公司提供的数 据统计，在2025年12月4日至2026年1月5日要约收购期限内，最终有3763个账户，共计约2.98亿股股份 接受收购人发出的要约，根据要约收购报告书，若预受要约股份的数量超过约1.89亿股，收购人按照同 等比例收购预受要约的股份，计算公式如下：收购人从每个预受要约股东处购买的股份数量＝该股东预 受要约的股份数×（1.89亿÷要约期间所有股东预受要约的股份总数）。收购人从每名预受要约的股东处 购买的股份如涉及不足一股的余股，则将按照中登公司权益分派中零碎股的处理办法进行处理。 本次要约收购完成后，收购人中种集团持有公司约3.83亿股股份，占公司总股本的40 ...

人民财讯1月8日电，荃银高科（300087）1月8日公告，截至本公告日，中国种子集团有限公司(简称"中 种集团")要约收购期限已届满。本次要约收购完成后，中种集团持有公司3.84亿股股份，占公司总股本 的40.51%。公司股票将于1月9日上午开市起复牌。 ...

截至 2026 年 1 月 5 日，本次要约收购期限已届满。根据中国证 券登记结算有限责任公司深圳分公司（以下简称"中登公司深圳分公 司"）提供的数据统计，本次要约收购期限内，预受要约的股东账户 总数为 3,763 户，预受要约股份总数为 297,787,643 股。其中贾桂兰 女士、王玉林先生已经按照其承诺以所持荃银高科 65,521,411 股、 8,831,109 股（合计 74,352,520 股）股份就本次要约收购预受要约。 中种集团已按照《安徽荃银高科种业股份有限公司要约收购报告书》 的约定，按照同等比例收购预受要约的股份，最终收购股份数量为 189,466,350 股。 中种集团已按照深圳证券交易所和中登公司深圳分公司的有关 规定履行了相关义务。截至本公告披露日，本次要约收购清算过户手 续已经办理完毕，中种集团持有荃银高科 383,760,376 股股份，占上 市公司总股本的 40.51%。 证券代码：300087 证券简称：荃银高科 公告编号：2026-003 安徽荃银高科种业股份有限公司 关于中国种子集团有限公司要约收购公司股份完成过户的公告 | 本公司及董事会全体成员保证信息披露的内容真实 ...

证券代码：300087 证券简称：荃银高科 公告编号：2026-004 安徽荃银高科种业股份有限公司 关于中国种子集团有限公司要约收购结果 暨股票复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.安徽荃银高科种业股份有限公司（以下简称"公司"或"上市 公司"，股票简称：荃银高科，股票代码：300087）将于 2026 年 1 月 9 日（星期五）上午开市起复牌。 2.在 2025 年 12 月 4 日至 2026 年 1 月 5 日要约收购期限内，最 终有 3,763 个账户，共计 297,787,643 股股份接受收购人中国种子集 团有限公司（以下简称"中种集团"或"收购人"）发出的要约，根 据要约收购报告书，若预受要约股份的数量超过 189,466,350 股，收 购人按照同等比例收购预受要约的股份，计算公式如下：收购人从每 个预受要约股东处购买的股份数量＝该股东预受要约的股份数× （189,466,350 股÷要约期间所有股东预受要约的股份总数）。收购 人从每名预受要约的股东处购买的股份如涉及不足一股的余股，则将 按照中国证券登 ...